Long-Term Follow-up of Subjects Who Were Treated With ST-920
NCT05039866
·
clinicaltrials.gov ↗
ENROLLING_BY_INVITATION
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Fabry Disease
Fabry Disease, Cardiac Variant
Interventions
BIOLOGICAL:
ST-920
Sponsor
Sangamo Therapeutics